| Spectrin regulates Hippo signaling by modulating cortical actomyosin activity H Deng, W Wang, J Yu, Y Zheng, Y Qing, D Pan Elife 4, e06567, 2015 | 104 | 2015 |
| The Hippo effector Yorkie activates transcription by interacting with a histone methyltransferase complex through Ncoa6 Y Qing, F Yin, W Wang, Y Zheng, P Guo, F Schozer, H Deng, D Pan Elife 3, e02564, 2014 | 77 | 2014 |
| Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC MV Negrao, HA Araujo, G Lamberti, AJ Cooper, NS Akhave, T Zhou, ... Cancer discovery 13 (7), 1556-1571, 2023 | 48 | 2023 |
| A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysis EE Manasanch, G Han, R Mathur, Y Qing, Z Zhang, H Lee, DM Weber, ... Blood Advances 3 (15), 2400-2408, 2019 | 29 | 2019 |
| Identification of biomarkers of immune checkpoint blockade efficacy in recurrent or refractory solid tumor malignancies RK Yang, Y Qing, FZ Jelloul, MJ Routbort, P Wang, K Shaw, J Zhang, ... Oncotarget 11 (6), 600, 2020 | 19 | 2020 |
| Corrected calcium versus ionized calcium measurements for identifying hypercalcemia in patients with multiple myeloma MJ Buege, B Do, HC Lee, DM Weber, SB Horowitz, L Feng, Y Qing, ... Cancer treatment and research communications 21, 100159, 2019 | 17 | 2019 |
| Proton Image-guided radiation assignment for therapeutic escalation via selection of locally advanced head and neck cancer patients [PIRATES]: a phase I safety and feasibility … LV van Dijk, SJ Frank, Y Yuan, B Gunn, AC Moreno, ASR Mohamed, ... Clinical and translational radiation oncology 32, 35-40, 2022 | 8 | 2022 |
| Pembrolizumab in patients with refractory cutaneous squamous cell carcinoma: a phase II trial R Ferrarotto, LG Sousa, Y Qing, D Kaya, B Stephen, D Jain, D Bell, S Pant, ... Advances in Therapy 38 (8), 4581-4591, 2021 | 8 | 2021 |
| Autologous stem cell transplantation for untreated transformed indolent B‐cell lymphoma in first remission: an international, multi‐centre propensity‐score‐matched study CK Chin, KJ Lim, K Lewis, P Jain, Y Qing, L Feng, CY Cheah, JF Seymour, ... British Journal of Haematology, 2020 | 8 | 2020 |
| Pilot study of pembrolizumab for immunoprevention in smoldering multiple myeloma EE Manasanch, R Mathur, HC Lee, DM Weber, KK Patel, SK Thomas, ... Blood 130, 3089, 2017 | 6 | 2017 |
| Induction chemotherapy with or without erlotinib in patients with head and neck squamous cell carcinoma amenable for surgical resection X Le, FO Gleber-Netto, ML Rubin, Y Qing, R Du, M Kies, ... Clinical Cancer Research 28 (13), 2796-2806, 2022 | 5 | 2022 |
| Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma CK Chin, MA Rodriguez, Y Qing, L Feng, F Samaniego, P Jain, M Noorani, ... Leukemia & Lymphoma 61 (12), 2985-2989, 2020 | 5 | 2020 |
| Subanesthetic ketamine in the ambulatory setting for refractory cancer pain: a 6-year retrospective at a cancer center M Chung, B Benkli, C Roldan, Y Qing, J Wang, B Huh Pain management 11 (3), 267-276, 2021 | 2 | 2021 |
| The Effect of Metformin on Vestibular Schwannoma Growth: A Systematic Review and Meta‐analysis BD Lovin, AJ Wilkinson, Y Qing, M Hernandez, ME Nader, S Raza, ... The Laryngoscope 133 (9), 2066-2072, 2023 | 1 | 2023 |
| Short- and Long-Term Outcomes of Hematologic Malignancy Patients After Cardiopulmonary Resuscitation: Experience of a Large Oncology Center MD Mary Lou Warren, DNP, APRN, CNS-CC, FCCM and Virginia V. Schneider, MPAS ... Journal of the Advanced Practitioner in Oncology 12 (7), 2021 | 1 | 2021 |
| Revisiting Feeding Tube Utilization in Oropharynx Cancer: 6‐Year Prospective Registry Analysis BJ Anderson, AC Moreno, Y Qing, JJ Lee, FM Johnson, MN Lango, ... Otolaryngology–Head and Neck Surgery, 2024 | | 2024 |
| Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma N Thongon, F Ma, N Baran, P Lockyer, J Liu, C Jackson, A Rose, ... Nature Communications 15 (1), 1-13, 2024 | | 2024 |
| Losartan Does Not Prevent Vestibular Schwannoma Growth Or Related Hearing Loss During Observation BD Lovin, ME Nader, Y Qing, M Hernandez, S Raza, F DeMonte, ... Journal of Neurological Surgery Part B: Skull Base 85 (S 01), S147, 2024 | | 2024 |
| A Bayesian piecewise exponential phase II design for monitoring a time‐to‐event endpoint Y Qing, PF Thall, Y Yuan Pharmaceutical statistics 22 (1), 34-44, 2023 | | 2023 |
| Targeting DNA2 Overcomes Metabolic Reprogramming in 1q21 Multiple Myeloma N Thongon, F Ma, M Marchesini, J Liu, N Baran, P Lockyer, A Santoni, ... | | 2022 |
